1652 related articles for article (PubMed ID: 24021029)
1. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic migraine: a 3-month comparator study of naproxen sodium vs SumaRT/Nap.
Cady R; Nett R; Dexter K; Freitag F; Beach ME; Manley HR
Headache; 2014 Jan; 54(1):80-93. PubMed ID: 24020994
[TBL] [Abstract][Full Text] [Related]
3. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological synergy: the next frontier on therapeutic advancement for migraine.
Blumenfeld A; Gennings C; Cady R
Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151
[TBL] [Abstract][Full Text] [Related]
5. Multi-center comparison of response to a single tablet of sumatriptan 85 mg and naproxen 500 mg vs usual therapy treating multiple migraine attacks as measured by the completeness of response survey.
Cady R; Banks J; Nett RB; Goldstein J; Bennett N; Turner IM; Ruoff GE; Landy SH; Farmer K; Juhász M; Tarrasch J; Runken MC
Headache; 2011 Jun; 51(6):961-70. PubMed ID: 21592098
[TBL] [Abstract][Full Text] [Related]
6. Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence.
Winner P; Linder S; Hershey AD
Headache; 2015 Apr; 55(4):519-28. PubMed ID: 25881677
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine.
Derosier FJ; Lewis D; Hershey AD; Winner PK; Pearlman E; Rothner AD; Linder SL; Goodman DK; Jimenez TB; Granberry WK; Runken MC
Pediatrics; 2012 Jun; 129(6):e1411-20. PubMed ID: 22585767
[TBL] [Abstract][Full Text] [Related]
8. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
9. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents.
McDonald SA; Hershey AD; Pearlman E; Lewis D; Winner PK; Rothner D; Linder SL; Runken MC; Richard NE; Derosier FJ
Headache; 2011 Oct; 51(9):1374-87. PubMed ID: 21797863
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
Calhoun AH; Ford S
Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
[TBL] [Abstract][Full Text] [Related]
11. Sumatriptan plus naproxen for acute migraine attacks in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2013 Oct; (10):CD008541. PubMed ID: 24142431
[TBL] [Abstract][Full Text] [Related]
12. Sumatriptan plus naproxen for the treatment of acute migraine attacks in adults.
Law S; Derry S; Moore RA
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD008541. PubMed ID: 27096438
[TBL] [Abstract][Full Text] [Related]
13. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
14. Promethazine plus sumatriptan in the treatment of migraine: a randomized clinical trial.
Asadollahi S; Heidari K; Vafaee R; Forouzanfar MM; Amini A; Shahrami A
Headache; 2014 Jan; 54(1):94-108. PubMed ID: 24182419
[TBL] [Abstract][Full Text] [Related]
15. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.
Brandes JL; Kudrow D; Stark SR; O'Carroll CP; Adelman JU; O'Donnell FJ; Alexander WJ; Spruill SE; Barrett PS; Lener SE
JAMA; 2007 Apr; 297(13):1443-54. PubMed ID: 17405970
[TBL] [Abstract][Full Text] [Related]
16. Twelve-month tolerability and safety of sumatriptan-naproxen sodium for the treatment of acute migraine.
Winner P; Cady RK; Ruoff GE; Frishberg BM; Alexander WJ; Zhang Y; Kori SH; Lener SE
Mayo Clin Proc; 2007 Jan; 82(1):61-8. PubMed ID: 17285787
[TBL] [Abstract][Full Text] [Related]
17. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.
Haberer LJ; Walls CM; Lener SE; Taylor DR; McDonald SA
Headache; 2010 Mar; 50(3):357-73. PubMed ID: 20132340
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan-naproxen migraine efficacy in allodynic patients: early intervention.
Landy S; Hoagland R; Hoagland NA
Headache; 2012 Jan; 52(1):133-9. PubMed ID: 21883200
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
20. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
